C3.ai Faces Class Action Lawsuit Over Alleged Securities Fraud
A class action lawsuit has been filed against C3.ai, Inc. (NYSE: AI) over alleged securities fraud. Investors claim the company misled them about its growth and the impact of its CEO's health issues between February 26, 2025 and August 8, 2025. The news has sent the company's stock price plummeting.
The lawsuit, filed on behalf of aggrieved shareholders, alleges that C3.ai made false and misleading statements about its growth prospects and the impact of its CEO's health problems on the company's performance. The CEO's health issues, which impaired the company's ability to close contracts, were reported in connection with a comprehensive sales reorganization. On August 8, 2025, C3.ai announced disappointing financial results and reduced revenue guidance, attributing the poor performance to leadership changes and the CEO's health issues. Following this announcement, the price of C3.ai's common stock fell by approximately 25.58% in a single day.
Investors who suffered losses during this time frame have until October 21, 2025 to request that the Court appoint them as lead plaintiff in the lawsuit. Levi & Korsinsky, LLP, a law firm with a track record of securing hundreds of millions of dollars for aggrieved shareholders, is representing investors in this case.
The lawsuit seeks to hold C3.ai accountable for allegedly misleading investors about its growth and the impact of its CEO's health issues. Investors who wish to participate in the lawsuit have until October 21, 2025 to take action.
Read also:
- Crooked House Pub's Demolition: Council Orders Rebuild, Debate on Historic Building Protections
- Shaping India's Economic Progression: Readying the Financial System for Tomorrow
- Conflict between Ben & Jerry's co-founder and Unilever over Gaza issues leads to resignation of co-founder
- Two farmers in Zambia take legal action against two firms with Chinese connections, alleging an ecological disaster caused by their operations.
